Real-world data from 12112 patients demonstrates that GLP-1 receptor agonists may significantly redu...
ASCO 2026: GLP-1s could reduce the risk of some obesity-related cancers progressing
Real-world data from 12112 patients demonstrates that GLP-1 receptor agonists may significantly reduce metastatic progression in four obesity-related...
Author: Oncology Central
Read Original Article